Celine Halioua
Celine Halioua is the Founder and CEO of Loyal, a clinical-stage animal health company
developing the first longevity drugs for dogs. Since founding Loyal in 2019, she has raised over $150M and has led the company through several historic regulatory milestones, including earning what is believed to be the first- and second-ever acceptances from the FDA that a drugcould be effectively developed for lifespan extension.
Prior to Loyal, Celine was Chief of Staff at the Longevity Fund and pursued a DPhil in the
economics of healthcare at Oxford University. She holds a B.S. in neuroscience from the
University of Texas at Austin.
Dain Clare
Denise Bevers
Brian Cassell
Steve Merchant
Greg Geckles
Betsy Watkins
Ester Banque
Kurt K. Lunkenheimer
Kurt K. Lunkenheimer is a partner at Cozen O’Connor, a full-service Am Law 100 firm. He defends companies and individuals in the context of government or internal investigations, enforcement actions, and civil or criminal trials.
Kurt served as an assistant U.S. attorney in the Southern District of Florida for 13 years. As deputy chief in the International Narcotics and Money Laundering Section and deputy chief in the Major Crimes Section, he led a wide range of high-profile investigations. Kurt first-chaired or supervised nearly 30 trials to verdict, including prosecution of international drug trafficking, money laundering, Office of Foreign Assets Control and Foreign Corrupt Practices Act violations, and alien smuggling, among other crimes.